Skip to main content

Table 3 Odds ratios for prior antibiotic a use in individuals with coeliac disease

From: Antibiotic exposure and the development of coeliac disease: a nationwide case–control study

 

Coeliac disease

 

Cases

Controls

Odds ratio

95% CI

 

n = 2,933 (%)

n = 14,571 (%)

  

Type of antibiotics used b

    

 Penicillin V

291 (9.9)

1308 (9.0)

1.12

0.98 – 1.27

 Extended spectrum penicillins

183 (6.2)

657 (4.5)

1.38

1.18 – 1.63

 Quinolones

51 (1.7)

170 (1.2)

1.46

1.08 – 1.97

 Macrolides

53 (1.8)

180 (1.2)

1.44

1.07 – 1.93

 Other systemic antibiotics

291 (9.9)

1041 (7.1)

1.42

1.24 – 1.62

Antibiotic use in the last year preceding diagnosis/study entry

    

 Any antibiotic

722 (24.6)

2730 (18.7)

1.42

1.29 - 1.56

 Penicillin V

259 (8.8)

1162 (8.0)

1.12

0.97 - 1.28

 Extended spectrum penicillins

166 (5.7)

559 (3.8)

1.46

1.23 - 1.74

 Quinolones

45 (1.5)

153 (1.1)

1.43

1.04 - 1.98

 Macrolides

48 (1.6)

150 (1.0)

1.55

1.13 - 2.11

 Other systemic antibiotics

206 (8.9)

905 (6.2)

1.47

1.26 - 1.66

  1. Odds ratios estimated through conditional logistic regression modelling.
  2. a See Additional file 4 for anatomical therapeutic chemical codes used to classify systemic antibiotics (J01).
  3. b Antibiotics used between July 1st 2005 and January 29th 2008.